Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Current Pharmaceutical Design
|
September 11, 2008
The endocannabinoid system in Huntington's disease
M R Pazos, O Sagredo, J Fernández-Ruiz
Life Sciences
|
August 13, 2004
Role of the endocannabinoid system in Alzheimer's disease: new perspectives
M R Pazos, E Núñez, C Benito, et al.
British Journal of Pharmacology
|
October 16, 2007
Cannabinoid CB2 receptors in human brain inflammation
C Benito, R M Tolón, M R Pazos, et al.
Neuroscience
|
April 11, 2008
Colocalization of CB1 receptors with L1 and GAP-43 in forebrain white matter regions during fetal rat brain development: evidence for a role of these receptors in axonal growth and guidance
M Gómez, M L Hernández, M R Pazos, et al.
Anales De Medicina Interna (Madrid, Spain : 1984)
|
March 1, 1989
[Paraquat poisoning: clinical and anatomopathologic aspects in 3 cases]
M R Pazos, R Reig, P Sanz, et al.
Neuropharmacology
|
June 5, 2012
Cannabidiol administration after hypoxia-ischemia to newborn rats reduces long-term brain injury and restores neurobehavioral function
M R Pazos, V Cinquina, A Gómez, et al.
Journal of Toxicology. Clinical Toxicology
|
December 1, 1982
Acute thallium poisoning: an evaluation of different forms of treatment
S Nogué, A Mas, A Parés, et al.
Cell Death & Disease
|
October 19, 2013
The inhibition of 2-arachidonoyl-glycerol (2-AG) biosynthesis, rather than enhancing striatal damage, protects striatal neurons from malonate-induced death: a potential role of cyclooxygenase-2-dependent metabolism of 2-AG
S Valdeolivas, M R Pazos, T Bisogno, et al.
Pharmacological Research
|
March 26, 2016
Biological characterization of PM226, a chromenoisoxazole, as a selective CB2 receptor agonist with neuroprotective profile
M Gómez-Cañas, P Morales, L García-Toscano, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Current Pharmaceutical Design
|
September 11, 2008
The endocannabinoid system in Huntington's disease
M R Pazos, O Sagredo, J Fernández-Ruiz
Life Sciences
|
August 13, 2004
Role of the endocannabinoid system in Alzheimer's disease: new perspectives
M R Pazos, E Núñez, C Benito, et al.
British Journal of Pharmacology
|
October 16, 2007
Cannabinoid CB2 receptors in human brain inflammation
C Benito, R M Tolón, M R Pazos, et al.
Neuroscience
|
April 11, 2008
Colocalization of CB1 receptors with L1 and GAP-43 in forebrain white matter regions during fetal rat brain development: evidence for a role of these receptors in axonal growth and guidance
M Gómez, M L Hernández, M R Pazos, et al.
Anales De Medicina Interna (Madrid, Spain : 1984)
|
March 1, 1989
[Paraquat poisoning: clinical and anatomopathologic aspects in 3 cases]
M R Pazos, R Reig, P Sanz, et al.
Neuropharmacology
|
June 5, 2012
Cannabidiol administration after hypoxia-ischemia to newborn rats reduces long-term brain injury and restores neurobehavioral function
M R Pazos, V Cinquina, A Gómez, et al.
Journal of Toxicology. Clinical Toxicology
|
December 1, 1982
Acute thallium poisoning: an evaluation of different forms of treatment
S Nogué, A Mas, A Parés, et al.
Cell Death & Disease
|
October 19, 2013
The inhibition of 2-arachidonoyl-glycerol (2-AG) biosynthesis, rather than enhancing striatal damage, protects striatal neurons from malonate-induced death: a potential role of cyclooxygenase-2-dependent metabolism of 2-AG
S Valdeolivas, M R Pazos, T Bisogno, et al.
Pharmacological Research
|
March 26, 2016
Biological characterization of PM226, a chromenoisoxazole, as a selective CB2 receptor agonist with neuroprotective profile
M Gómez-Cañas, P Morales, L García-Toscano, et al.
Page
of 1